Pan-cancer analysis of SPINT2 reveals context-dependent patterns and prognostic relevance across solid cancers
Abstract
Serine Protease Inhibitor Kunitz type-2 (SPINT2) has been reported to play a role in the progression of various tumor types. This inhibitor is generally described as a tumor suppressor that affects migration and invasion. However, a few recent studies have reported the opposite, suggesting an oncogenic role for SPINT2 . Understanding how molecules influence cancer biology is crucial for their use as biomarkers, prognostic indicators, or therapeutic targets, thereby advancing personalized oncology. Hence, this study aims to characterize SPINT2 across solid tumors by evaluating its expression, regulatory mechanisms, and potential as a prognostic biomarker. An integrated approach using TCGA and CCLE datasets, patient samples and tumor cell lines was performed to assess SPINT2 expression, regulation, and clinical outcome associations across multiple solid tumor types. This study provides the first pan-cancer analysis of SPINT2 across 31 solid tumor types, including 13 not previously investigated. SPINT2 expression significantly decreased from normal to malignant tissue in 9 non-epithelial/atypical-epithelial tumors and increased in 17 typical epithelial carcinomas. Promoter methylation was higher in non-epithelial and lower in epithelial tumors, mirroring respective SPINT2 expression patterns. This lineage-associated pattern may help contextualize the discrepant tumor-suppressive and oncogenic roles reported for SPINT2 and is likely influenced by tumor origin and molecular context. SPINT2 expression was significantly associated with survival across three tumor types by univariate analysis, while multivariate analysis identified SPINT2 as an independent prognostic factor in six distinct tumor types. These findings support SPINT2 as a promising tumor-type-specific biomarker with associations that differ across neoplasms.
Related
- RAS Mutations as Prognostic Biomarkers in Digestive Cancers: From Binary Classification to Variant-Specific and Context-Dependent Risk Stratification
- Spatial Remodeling of the Immune Microenvironment During Laryngeal Carcinogenesis Reveals Prognostic Immune Patterns in Laryngeal Squamous Cell Carcinoma
- Multi-omics characterization of CAF-related transcriptional programs reveals a smoking-context-informed 11-gene prognostic signature in HNSCC.
- Scalable context-dependent single-cell eQTL mapping reveals disease-relevant regulatory variation beyond static models
- Integrated transcriptomics reveals a TNFRSF-metabolism axis and a context-dependent BCMA signaling state in myeloma progression.
BibTeX
@article{celeiro2026pancancer,
title = {{Pan-cancer analysis of SPINT2 reveals context-dependent patterns and prognostic relevance across solid cancers}},
author = {Sónia Pires Celeiro and Márcia Santos Pereira and Caroline Borges-Pereira and Sara Granja and Adhemar Longatto-Filho and Conceição Souto Moura and Croider Franco Lacerda and Sandra Fátima Fernandes Martins and Iara Viana Vidigal Santana and Denise Peixoto Guimarães and José Pimentel and Anna Luiza Silva Vicente and Vinicius de Lima Vazquez and Rui Manuel Reis and Marta Viana-Pereira},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-65688-x},
url = {https://www.nature.com/articles/s41598-026-65688-x},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Pan-cancer analysis of SPINT2 reveals context-dependent patterns and prognostic relevance across solid cancers
AU - Sónia Pires Celeiro
AU - Márcia Santos Pereira
AU - Caroline Borges-Pereira
AU - Sara Granja
AU - Adhemar Longatto-Filho
AU - Conceição Souto Moura
AU - Croider Franco Lacerda
AU - Sandra Fátima Fernandes Martins
AU - Iara Viana Vidigal Santana
AU - Denise Peixoto Guimarães
AU - José Pimentel
AU - Anna Luiza Silva Vicente
AU - Vinicius de Lima Vazquez
AU - Rui Manuel Reis
AU - Marta Viana-Pereira
PY - 2026
DA - 2026/10/07
JO - Scientific Reports
DO - 10.1038/s41598-026-65688-x
UR - https://www.nature.com/articles/s41598-026-65688-x
AB - Serine Protease Inhibitor Kunitz type-2 (SPINT2) has been reported to play a role in the progression of various tumor types. This inhibitor is generally described as a tumor suppressor that affects migration and invasion. However, a few recent studies have reported the opposite, suggesting an oncogenic role for SPINT2 . Understanding how molecules influence cancer biology is crucial for their use as biomarkers, prognostic indicators, or therapeutic targets, thereby advancing personalized oncology. Hence, this study aims to characterize SPINT2 across solid tumors by evaluating its expression, regulatory mechanisms, and potential as a prognostic biomarker. An integrated approach using TCGA and CCLE datasets, patient samples and tumor cell lines was performed to assess SPINT2 expression, regulation, and clinical outcome associations across multiple solid tumor types. This study provides the first pan-cancer analysis of SPINT2 across 31 solid tumor types, including 13 not previously investigated. SPINT2 expression significantly decreased from normal to malignant tissue in 9 non-epithelial/atypical-epithelial tumors and increased in 17 typical epithelial carcinomas. Promoter methylation was higher in non-epithelial and lower in epithelial tumors, mirroring respective SPINT2 expression patterns. This lineage-associated pattern may help contextualize the discrepant tumor-suppressive and oncogenic roles reported for SPINT2 and is likely influenced by tumor origin and molecular context. SPINT2 expression was significantly associated with survival across three tumor types by univariate analysis, while multivariate analysis identified SPINT2 as an independent prognostic factor in six distinct tumor types. These findings support SPINT2 as a promising tumor-type-specific biomarker with associations that differ across neoplasms.
SN - 2045-2322
ER -